Q2 2024 Apellis Pharmaceuticals Inc Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Apellis Pharmaceuticals Second Quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question and answer session to ask a question. During the session, you will need to press star one on your telephone.
You will then hear an automated message. Advising your hand is raised. To withdraw your question, please press star one. Again. Please be advised that today's conference is being recorded. I would now like to introduce, I would now like to hand the conference over to Meredith Kaya, Senior Vice President, Investor Relations and Strategic Finance. Please go ahead.
Good morning, and thank you for joining us to discuss Apellis Second Quarter 2024 financial results. With me on the call are Co-Founder and Chief Executive Officer, Dr. Cedric Francois, Chief Operating Officer, Adam Townsend, Chief Medical Officer,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |